Targacept Ends GSK Alliance, Regains NNR Program Rights
By Marie Powers
Friday, March 4, 2011
Following the decision last year by GlaxoSmithKline plc (GSK) to dial down its neuroscience research activities, Targacept Inc. has yanked its strategic alliance with GSK, effective May 29.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.